LivaNova PLC 1Q 2026: Revenue $362.26M, EPS $0.4— 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
LivaNova PLC reported a revenue of $362.26M for Q1 2026, marking a 14.3% increase from the previous year, with a diluted EPS of $0.4 compared to a loss of $6.01 in Q1 2025. The company achieved a net income of $22.29M, recovering from a loss of $327.32M a year ago. Growth was driven by strong demand in the U.S. and Europe, particularly in the cardiopulmonary and neuromodulation segments. R&D investments increased to support new developments, while operations remained stable despite global challenges.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments